3 learning resources available for this topic
Major Depressive Disorder (MDD) is a serious mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in activities for at least two weeks. It affects approximately 8-10% of adults worldwide and represents one of the leading causes of disability globally, significantly impacting daily functioning, relationships, and quality of life.
MDD involves complex interactions between genetic predisposition, environmental stressors, and neurobiological factors including dysregulation of neurotransmitters like serotonin, norepinephrine, and dopamine. Structural and functional brain changes occur in regions responsible for mood regulation, including the prefrontal cortex, hippocampus, and amygdala, along with disruptions in the hypothalamic-pituitary-adrenal axis affecting stress response.
Diagnosis requires comprehensive assessment of symptoms including depressed mood, anhedonia, sleep disturbances, appetite changes, fatigue, concentration difficulties, and suicidal ideation, with symptoms persisting for at least two weeks and causing significant functional impairment. Treatment typically involves a combination of psychotherapy (particularly cognitive-behavioral therapy) and pharmacotherapy (SSRIs, SNRIs, or other antidepressants), with response monitoring and adjustment based on symptom severity and patient-specific factors.